Abstract.-The extraneuronal spontaneous efflux of 3H-dopamine synthesized endogenously in dopamine terminals has been demonstrated in vitro, by collecting the 3H amine in superfusates of isolated striatum of the rat previously incubated with 3H-tyrosine. The 3H-dopamine newly synthesized appears to be preferentially released. Furthermore, amphetamine and a monoamine oxidase inhibitor (Catron) markedly increased the release of 3H-dopamine. This effect was also observed with substances normally contained in some striatal neurons: acetylcholine and 5-hydroxytryptamine.
Introduction.-The in vivo release of dopamine, a putative neurotransmitter found in high concentrations in the numerous varicosities of specific terminals of the caudate nucleus, has been shown in the cat in only a few studies. On the basis of experiments in which a push-pull cannula was used to "superfuse" an area of the caudate nucleus, McLennan1 reported that a resting-state release of dopamine could be observed; its release was enhanced by electrical stimulation of the nucleus centromedianus. Under similar experimental conditions, McKenzie and Szerb2 could identify the released amine precisely only when very high doses of D-amphetamine were simultaneously applied locally. Portig and co-workers3 have also demonstrated a pharmacologically inducible release of dopamine from the caudate nucleus; they detected the amine in ventricular perfusates following injections of d-tubocurarine. They also claimed that dopamine could be released by electrical stimulation of the substantia nigra, although that was not a consistent finding. Baldessarini and Kopin4 have shown that 3H-norepinephrine, taken up and stored in brain slices, can be released by field stimulation. They also reported similar results with H-dopamine.
Many observations, made both in vivo and in vitro, have revealed that radioactive catecholamines, taken up in brain tissue, label the endogenous amine stores5, but the possibility remains that small quantities of these 3H-amines may not be specifically localized. If so, this could have a serious implication to release studies because, as shown in peripheral adrenergic nerves, the amount of amine released and detectable extraneuronally appears to be quite small when compared to the intraneuronal amine content. 6 To avoid this possible objection to the use of exogenous 3H-dopamine and also to avoid the relatively low sensitivity of the fluorimetric dopamine assay, we have attempted to demonstrate and to study the release of 3H-dopamine, previously synthesized endogenously in dopamine-containing terminals from 3H-tyrosine of high specific activity. Under our experimental conditions, the mini-mal amount of 3H-dopamine detectable is about 5 to 10 pg (1000 times more sensitive than the dopamine fluorimetric assay). Furthermore, since tyrosine hydroxylase is exclusively distributed in catecholamine-containing neurons, the 3H-dopamine formed from 3H-tyrosine is specifically localized. Finally, this approach permits an analysis of the relationships between synthesis and release mechanisms.
With this experimental approach, the resting and pharmacologically inducible release of dopamine has been demonstrated in vitro in the isolated rat striatum and in vivo in the caudate nucleus of the curarized cat. In the cat studies, a caudate area is exposed by a local decortication and "superfused" by a modification of the cup technique used by Mitchell7 to demonstrate the cortical release of acetylcholine. Only the in vitro studies will be described in this report; the in vivo data will be presented in a separate publication.
MethAs.-Operative procedure: Sprague-Dawley male rats weighing 200-250 gm were decapitated, brains were immediately removed, and the striatum was dissected with glass manipulators at 40C. The isolated striata (approximately 50 mg) were incubated separately for 30 min at 370C in 100 1AI of a physiological medium (in mM: NaCi, 126.5; NaHCO3: 27.5; KCl, 2.4; KH2PO4, 0.5; CaCl2, 1.1; MgCl2, 0.83; Na2SO4, 0.5; glucose, 5.9; adjusted to pH 7.4 with a mixture of 02 and CO2, 95 and 5%, respectively) containing 15.6 ,uCi of L 3-5 3H-tyrosine (28.2 C/mM, Amersham), and constantly exposed to a flow of the Or-CO2 mixture. Immediately after incubation, tissues were washed for 1 min in 10 ml of the physiological oxygenated medium maintained at 37°C. Each striatum was then transferred to a 100-ld organ bath and "superfused" at 37°C with a continuous flow (6 ml/hr) of the oxygenated medium. Serial fractions of effluent medium were collected during 15-min intervals in cooled tubes containing 200 JAl of a "protective" solution (ascorbic acid, 1%; EDTA, 1.5%; dopamine, 0.001%) and 8 ml of absolute ethanol. After the "superfusion" period, striata were immediately homogenized in 5 ml of ethanolwater (3:1 v/v). Fractions and homogenates were kept at -17°C until analysis.
Biochemical determination: The total radioactivity of fractions and homogenate supernatants obtained after centrifugation was assayed in a small aliquot. 3H-dopamine was separated from 3H-tyrosine and 'H-metabolites by ion-exchange chromatography on amberlite CG-50 and by adsorption chromatography on alumina as described previously.8 The alumina eluates were evaporated to dryness under vacuum, and the radioactivity was measured by liquid scintillation counting. 3H-dopamine and 3H-tyrosine recoveries in alumina column eluates were 60 and 0.01%, respectively, an indication that the 3H-tyrosine overlap in 3H-dopamine determination is negligible. The 3H-tyrosine contamination of the 3H-dopamine never exceeded 5%.
3H-dopamine identification: In some experiments, the identity of 3H-dopamine present in alumina column eluates originating from tissue homogenates or of pooled collected fractions was checked by cochromatography after acetylation of the amine and organic extraction of the acetylated derivative.9
Results.-(1) Synthesis and utilization of 3H-dopamine: Total radioactivity and 3H-catecholamine contents of isolated striatum were estimated at the end of incubation and at various times during superfusion of the tissues (Fig. 1 ). The identification (as indicated in Methods) of the tissue 3H-catecholamines, one and three hours after the end of the incubation, clearly revealed only the presence of 3H-dopamine. The labeled amine represented 1 per cent of the total radioactivity at the end of the incubation. The 3H-dopamine tissue content increased by at least 65 per cent in the first hour of superfusion, an indication that the amine is still synthesized from its precursor during this period. In the follow- 11 (2) Demonstration of 3H-dopamine spontaneous release: A spontaneous efflux of 3H-dopamine could be demonstrated in the collected "superfusates." In our experimental conditions, 3H-dopamine released could be accurately estimated during the first two hours following the incubation period. Furthermore, the amine identity was demonstrated by cochromatography of the acetyl derivative. The dopamine identification was performed on pooled fractions obtained from six striata corresponding to the first 15 minutes of "superfusion" and on pooled fractions collected during the following 45 minutes. In both cases, 3H-dopamine could be identified in the alumina eluates of the pooled superfusates and represented total radioactivity of the eluates. 3H-dopamine found in the first fraction represented about 10 to 15 per cent of the tissue 3H-dopamine content. During the first 45 minutes (Fig. 2 ), the 3H-dopamine level in the successive collected fractions decayed rapidly. In the following 90 minutes, the half-life of this decay was slower, comparable to the tissue 3H-dopamine disappearance in this time interval.
The decline in total radioactivity (mainly 3H-tyrosine, approximately 95%) of the successive collected fractions differs in the initial 45-minute period from that of 3H-dopamine. Similar observations could be made for 140-urea (15 c/mole; C.E.A., France) and 3H-inulin (75 mc/gm; C.E.N., Belgium) when of 3H-dopamine was seen; no effect could be clearly detected with a 5 X 1O-6 M Ach solution. An enhanced release of 3H-dopamine was also observed with 5-HT (5 X 10O5 M) (Fig. 3) . The 3H-dopamine release induced by these drugs appears to be specific; the output of the total tritium, corresponding mainly to 3H-tyrosine, was never affected. Furthermore, it was demonstrated that Ach (5 X 1O6 M) did not modify the decay curves of 14C-urea or 3H-inulin in the collected fractions originating from isolated striata, previously incubated with these substances In preliminary experiments, in which the effect of ions was Discusion.-This in vitro study reveals the existence, in the rat striatum, of a resting as well as a drug-inducible efflux of dopamine synthesized intraneuronally from its initial precursor. Both phenomena have also been observed in vivo in preliminary studies performed on the cat caudate nucleus. They both seem also to reflect specific mechanisms.
The spontaneous output of 3H-dopamine observed may correspond to a normal resting release of the biogenic amine related to the features of dopamine metabolism in this structure. It should be noted that the curve of 3H-dopamine decay in the initial successive perfusate fractions appears different from those of 3H-tyrosine, 14C-urea, and 3H-inulin. The elimination of the last two compounds represents a diffusion of these substances from the extracellular space into the superfusing medium. Furthermore, under comparable experimental conditions we have observed that the output decay of 3H-5-hydroxytryptamine endogenously synthesized from 3H-tryptophane is slower than that of 3H-dopamine, as well as extraneuronally localized compounds. On the basis of experimental data, the existence of more than one storage pool for catecholamines in central neurons has been proposed.12 13 Moreover, it has been shown recently, in peripheral adrenergic neurons, that newly synthesized norepinephrine is preferentially released.14 Our data suggest that a similar process could operate in central dopaminergic neurons.
The amount of 3H-dopamine collected in the first 15 minutes is about 30 times greater than the 3H-dopamine content of the fraction collected 105 minutes later. However, the tissue 3H-dopamine contents just after the incubation and two hours after the onset of superfusion are almost equal. This suggests that all the 3H-dopamine in the tissue is not equally released; it is consistent with the possibility that newly synthesized 3H-dopamine is preferentially released in the resting state under our experimental conditions. Acetylcholine and 5-hydroxytryptamine, substances which are normally localized in high concentrations in some striatal neurons or endings and which are believed to act as neurotransmitters, produced a pronounced increase in the output of 3H-dopamine from the tissue. When quantities as low as 1l-moles were administered over a period of 15 minutes, the amount of 3H-dopamine released was 100 per cent greater than the value of the resting release during the previous 15 minutes. An effect could also be generally observed in the fractions collected immediately after 5-hydroxvtryptamine or acetylcholine addition. This may be due to the physiological effects of the transmitters on dopamine terminals or to diffusion characteristics of our experimental model. It should be noted that the effect induced by Ach was observed in presence of eserine which by itself showed only a slight or insignificant effect. As previously mentioned, the effect is probably a specific manifestation of the direct action of these substances on dopaminergic endings or on striatal interneurons acting on them. These dopamine terminals belong to the nigro-striatal system of dopamine neurons described on the basis of histochemical, autoradiographic, and lesion studies.16 The 3H-dopamine is localized in these dopamine terminals. Moreover, Ach had no effect on the output of 3H-tyrosine, probably located intra-and extraneuronally, nor on 14C-urea and 'H-inulin which were used as indicators of possible inducible physical changes in the extracellular space. Similar effects of Ach on norepinephrine terminals have been described in isolated spleen '6 or heart '7 18 preparations. The dopamine liberation induced by Ach may explain the effect of some cholinergic drugs, such as oxotremorine, on striatal dopamine metabolism.'9-2' The effects observed with acetycholine, as well as 5-hydroxytryptamine, provide an example of the diversity of the modulating factors acting on the release of dopamine from dopamine neurons.
On the basis of indirect evidence, various authors have suggested that among the various psychotropic drugs which act on the central nervous metabolism of catecholamines, monoamine oxidase inhibitors and amphetamine produce some of their physiological effects by increasing the concentration of catecholamines in the synaptic cleft.5' 1 ' The results presented in this report directly demonstrate the rapid extraneuronal increase in dopamine induced by these drugs. This may explain some of their clinical effects, particularly the increased motor activity induced by amphetamine. Both Catron and amphetamine, when administered at concentration 1/10 or 1/50 that of acetylcholine or 5-hydroxytryptamine, produced effects two to three times greater on 'H-dopamine output. In both cases this effect may be due to more than one action of these drugs on dopamine terminals: an increased availability of the amine in a small pool which can be released, a facilitating effect on the release process, and a blockade of the extraneuronal amine inactivation systems, for example, the extraneuronal monoamine oxidase or, more likely, the powerful reuptake process. The intraneuronal increase in catecholamines produced by inhibitors of monoamine oxidase is well known.5' 15 An effect of amphetamine due to monoamine oxidase inhibition cannot be ruled out; this drug has been shown to produce an increase of brain dopamine levels. 22' 23 Moreover, in in vitro studies, brain monoamine oxidase activity can be inhibited by amphetamine (at a concentration of 5 X 105 M).24 Such an action may increase the amount of dopamine available for extraneuronal release. The uptake processes in central norepinephrine and dopamine neurons are different24' 25 but amphetamine, which inhibits the reserpine-resistant uptake of norepinephine neurons,5 24, 25 may also be acting by this mechanism on central dopamine neurons.2-27 However, these effects are observed in vivo only when large doses of amphetamine are administered. 24' 27 It has recently been observed in histochemical studies that amphetamine given in low doses accelerates the disappearance of a-methyl-iioradrenaline previously accumulated in DA terminals of rats treated with reserpine and nialamide ;27 this fact was interpreted as a releasing action of the drug on these neurons. This hypothesis is supported and confirmed by our results; it is likely that the marked extraneuronal release of 3H-dopamine produced by low concentration of amphetamine is mainly due to a direct effect of this drug on the process of dopamine release.
These experiments, which reveal the release of dopamine under various pharmacological conditions, give further support to the concept of a neurotransmitter function of dopamine in nigro-striatal dopamine-containing neurons. MVoreover, the experimental model employed appears to be a useful tool to investigate VOL. 62, 1969 further the interrelationships between neurons acting with different chemical transmitters as well as to study the mechanism of action of some psychotropic drugs.
